Trials / Active Not Recruiting
Active Not RecruitingNCT06671470
A Drug-drug Interaction Study of YZJ-1139 Tablets and Ticagrelor Tablets in Healthy Subjects
Drug Interaction Study of YZJ-1139 Tablets With Ticagrelor Tablets
- Status
- Active Not Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 27 (actual)
- Sponsor
- Shanghai Haiyan Pharmaceutical Technology Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
Primary Objective : To evaluate the effect of ticagrelor tablets on the pharmacokinetic characteristics of YZJ-1139 in healthy subjects; Secondary Objective: To evaluate the safety of ticagrelor tablets in combination with YZJ-1139 tablets in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | YZJ-1139 tablets | Oral dose 20 mg |
| DRUG | Ticagrelor Tablets | Oral dose 90 mg twice daily |
Timeline
- Start date
- 2024-08-22
- Primary completion
- 2024-09-13
- Completion
- 2024-12-01
- First posted
- 2024-11-04
- Last updated
- 2024-11-04
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06671470. Inclusion in this directory is not an endorsement.